Profhilo H-L (2ml) – Bioremodeling Solution

Description

Profhilo H-L is a revolutionary, award-winning injectable bioremodeling treatment developed by IBSA Derma (Italy). Operating completely apart from traditional dermal fillers, it is the first crosslinked-free hyaluronic acid injectable engineered using patented NAHYCO® Hybrid Technology. This advanced thermal process merges an ultra-high concentration of high-molecular-weight HA and low-molecular-weight HA into stable, cooperative hybrid complexes without the use of chemical crosslinking agents like BDDE. Delivering 64 mg of pure HA per 2ml syringe, Profhilo spreads smoothly through the tissue matrix to trigger deep cellular remodeling. It directly stimulates four distinct types of collagen and elastin, restoring natural tissue volume, correcting skin laxity, and providing unmatched, honey-like hydration across the dermal layer.

Main Benefits of Profhilo H-L

• BDDE-Free Cellular Safety: Formulated through a clean thermal fusion process rather than chemical crosslinking agents, dramatically lowering the risk of post-injection hypersensitivity or granulomas.

• Dual-Action Bioremodeling: Simultaneously fuels deep epidermal hydration via low-weight HA molecules while building an elastic structural framework via high-weight HA chains.

• Active Neo-Collagenesis: Directly instructs tissue receptors to produce four types of collagen (Types I, III, IV, and VII) and fresh elastin to tighten thinning, saggy skin.

• High Spreadability & Minimal Punctures: The low-viscosity fluid flows smoothly through tissue planes, allowing a full facial treatment using only 5 strategic points per side.

• Adipocyte Tissue Preservation: Supports the health and stability of subcutaneous fat cells, helping prevent the facial fat hollowing that naturally occurs with chronological aging.

Indications

Profhilo H-L is indicated for the structural remodeling and multi-level rehydration of thinning, loose, or dull tissue profiles showing signs of early to advanced dermal degradation:

• Malar and Submalar Skin Laxity: Tightening loose skin along the mid-face, lower cheeks, and jawline perimeters.

• Epidermal Texture Crepiness: Smoothing out thin, paper-like skin texuring on the face, neck, and upper décolleté.

• Chronic Matrix Dehydration: Plumping up sallow, tired, or dry skin profiles that have lost natural thickness and bounce.

• Hard-to-Treat Body Zones: Re-densifying fragile, loose skin on the backs of the hands, inner upper arms, and over-the-knee regions.

Technical Specifications

Feature	Specification
Product Name	Profhilo H-L
Manufacturer	IBSA Farmaceutici Italia / IBSA Derma (Italy)
Active HA Concentration	3.2% – 64 mg total Hyaluronic Acid per 2ml syringe
Hybrid Composition	32 mg High Molecular Weight HA (1100-1400 kDa) + 32 mg Low Molecular Weight HA (80-100 kDa)
Crosslinking Type	100% Free of BDDE; Thermally stabilized NAHYCO® cooperative complexes
Packaging Layout	1 x 2ml Pre-filled sterile glass syringe per retail pack
Included Needles	2 x Terumo 29G x ½” ultra-thin wall sterile needles
Injection Layer	Deep dermis or superficial subcutaneous plane
Injection Protocols	5-Point BAP (Bio Aesthetic Points) technique for face or neck
Standard Session Cycle	2 loading sessions spaced 4 weeks apart; optional 3rd session for severe laxity
Storage Parameters	Store safely between 2°C to 25°C; protect from freezing and direct heat sources

Mechanism of Action

Profhilo H-L remodels aged skin matrices through a synchronized Thermal Hybrid Matrix Integration pathway:

1. High-Diffusion Dermal Saturation: Unlike thick, crosslinked fillers that stay in a tight bolus where injected, Profhilo’s thermally fused hybrid network has high fluidity. It spreads smoothly across wide anatomical zones, settling into interstitial tissue spaces.

2. Multilevel Receptor Signaling: The low-molecular-weight HA slowly detaches from the hybrid matrix to bind with CD44 cell receptors, triggering keratinocytes and fibroblasts to multiply. Meanwhile, the high-molecular-weight HA provides a physical, elastic cushion.

3. Active Structural Remodeling: This sustained cellular activation prompts fibroblasts to actively synthesize new Type I and Type III collagen, along with structural elastin. This process thickens the extracellular matrix, pulling loose tissue upward for a natural, non-filled lifting effect.

Administration Protocol

• Delivery Formats: Administered by licensed skincare professionals using the specialized Bio Aesthetic Points (BAP) Technique. This protocol maps out 5 precise, nerve-free injection zones per side of the face (zygomatic protrusion, nasal ala, tragus, chin, and mandibular angle) to maximize product diffusion while minimizing bruising risks.

• Optimal Placement Depth: Must be placed cleanly into the deep dermis or the superficial subcutaneous boundary layer. Injection is delivered as a 0.2ml bolus per point.

• The Recommended Session Cycle:

  • Phase 1 (Initial Loading): 2 individual treatment sessions spaced exactly 4 weeks apart.

  • Phase 2 (Booster Maintenance): 1 single maintenance treatment every 5 to 6 months to sustain fibroblastic activity, skin firmness, and intense moisture retention.

• Post-Treatment Guidelines: Small, localized bumps resembling insect bites will appear at the BAP injection points immediately following the session. These are normal and represent the concentrated product matrix waiting to diffuse; they typically flatten out completely within 12 to 24 hours. Patients should avoid strenuous exercise, steam rooms, and applying heavy makeup for 24 hours.

FAQ

Q: Is Profhilo a dermal filler or a mesotherapy skin booster?

A: It is neither; Profhilo belongs to its own distinct category called Bioremodeling. Traditional fillers use crosslinking chemicals (like BDDE) to add localized volume or reshape features (like lips or cheeks). Mesotherapy skin boosters provide brief, superficial surface hydration. Profhilo uses thermally stabilized HA to trigger cell renewal, clearing skin laxity and remodeling tissue thickness over a wide area without inflating the face.

Q: Why does the patient require only 5 injection points per side of the face?

A: Due to its unique NAHYCO® thermal processing, Profhilo has high fluid movement through tissue layers. When placed in the 5 strategic Bio Aesthetic Points (BAP), the product naturally spreads through the surrounding skin planes over 24 to 48 hours. This replaces the need for dozens of micro-papules, making the procedure faster, safer, and far more comfortable.

Q: When will my patients begin to see the lifting and hydrating effects?

A: Patients typically notice an immediate boost in skin moisture and a brighter complexion within the first week. The structural lifting, skin tightening, and elasticity improvements develop more gradually as fresh collagen production scales up, peaking roughly 4 weeks after the second loading session.

IMPORTANT NOTICE ON INTELLECTUAL PROPERTY

This online storefront operates as an independent, autonomous vendor of genuine medical aesthetic items. We hold no formal commercial affiliation, partnership, or authorized distribution rights with IBSA Farmaceutici Italia, IBSA Derma, or the Profhilo product line. All brand names, logos, technical titles, and registered trademarks listed here are the property of their respective owners. Their use on this site is solely for identifying and describing the authentic products we independently offer.